Literature DB >> 21686743

Sarcoidosis with basal ganglial infiltration presenting as Parkinsonism.

Spyridon Papapetropoulos1, Alexandra Guevara, Michael Georgiou, Georgia Mitsi, Carlos Singer, Sylvia Delgado.   

Abstract

The present report describes the case of a woman with symptoms of Parkinsonism (slow and monotonous speech, left foot dragging and micrographia) that gradually developed over a period of 12 months. She had a 10-month history of untreated, asymptomatic sarcoidosis diagnosed by routine biopsy of an enlarged left supraclavicular lymph node. After her condition deteriorated, a brain MRI showed right basal ganglial areas of haemorrhage with perilesional fast fluid-attenuated inversion-recovery (FLAIR) abnormalities. Right stereotactic frame-based brain parenchymal biopsy of the lesion site revealed reactive central nervous system (CNS) tissue with perivascular chronic inflammation and non-caseating granulomas consistent with definite neurosarcoidosis. The patient was started on a high dose of prednisone with good initial response. When mild progression was noted within the next 12 months azathioprine was added to her treatment. The patient's neurological status has been stable without progression of her Parkinsonian symptomatology.

Entities:  

Year:  2009        PMID: 21686743      PMCID: PMC3027760          DOI: 10.1136/bcr.07.2008.0569

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Cerebral sarcoidosis presenting as supranuclear gaze palsy with hypokinetic rigid syndrome.

Authors:  U Schlegel; P Clarenbach; A Cordt; A Steudel
Journal:  Mov Disord       Date:  1989       Impact factor: 10.338

2.  Neurosarcoidosis.

Authors:  D G James; O P Sharma
Journal:  Proc R Soc Med       Date:  1967-11-01

Review 3.  Sarcoidosis and its neurological manifestations.

Authors:  B J Stern; A Krumholz; C Johns; P Scott; J Nissim
Journal:  Arch Neurol       Date:  1985-09

Review 4.  Neurosarcoidosis: a clinical dilemma.

Authors:  Elske Hoitsma; Carin G Faber; Marjolein Drent; Om P Sharma
Journal:  Lancet Neurol       Date:  2004-07       Impact factor: 44.182

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.